CSIMarket



Imara inc.  (IMRA)
Other Ticker:  
 
 

IMRA's Capital Expenditures Growth by Quarter and Year

Imara's Capital Expenditures results by quarter and year




IMRA Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - - - 0.00
III Quarter September - - - 0.00
II Quarter June 0.21 - 0.01 0.00
I Quarter March 0.14 0.01 0.02 0.00
FY   0.35 0.01 0.03 -



IMRA Capital Expenditures second quarter 2022 Y/Y Growth Comment
Imara inc. in the second quarter 2022 achieved Capital Expenditures of $ 0.21 millions compare to Capital Expenditures recorded in same quarter a year ago.

Looking into second quarter 2022 results within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Capital Expenditures growth. While Imara Inc.' s Capital Expenditures no change of % ranks overall at the positon no. 195 in the second quarter 2022.




IMRA Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March 1300 % -50 % - -
FY   - -66.67 % - -

Financial Statements
Imara's second quarter 2022 Capital Expenditures $ 0.21 millions IMRA's Income Statement
Imara's second quarter 2021 Capital Expenditures $ 0.00 millions Quarterly IMRA's Income Statement
New: More IMRA's historic Capital Expenditures Growth >>


IMRA Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June 47.86 % - -50 % -
I Quarter March - - - -
FY (Year on Year)   - -66.67 % - -




Capital Expenditures second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #32
Overall #195

Capital Expenditures Y/Y Growth Statistics
High Average Low
53.33 % -50 % -100 %
(Jun 30 2022)   (Jun 30 2021)
Capital Expenditures second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #32
Overall #195
Capital Expenditures Y/Y Growth Statistics
High Average Low
53.33 % -50 % -100 %
(Jun 30 2022)   (Jun 30 2021)

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Imara's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
53.33 % -50 % -100 %
(Jun 30 2022)  


IMRA's II. Quarter Q/Q Capital Expenditures Comment
Imara inc. achieved in the II. Quarter 2022 above company average sequential Capital Expenditures jump of 47.86%, to $ 0.21 millions, from $0.14 millions in the first quarter.
Imara is impressively improving, not only reporting above average gain, but also increasing speed.

Within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Imara's Capital Expenditures growth quarter on quarter, overall rank is 195.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #32
Overall #195
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #9
Healthcare Sector #32
Overall #195
Capital Expenditures Q/Q Growth Statistics
High Average Low
53.33 % -50 % -100 %
(Jun 30 2022)  


IMRA's II. Quarter Q/Q Capital Expenditures Comment
Imara inc. achieved in the II. Quarter 2022 above company average sequential Capital Expenditures jump of 47.86%, to $ 0.21 millions, from $0.14 millions in the first quarter.
Imara is impressively improving, not only recording higher then average increase, and also increasing speed.

Within Major Pharmaceutical Preparations industry 8 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Imara's Capital Expenditures growth quarter on quarter, overall rank is 195.


Imara's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Jun 30 2022 period, Imara's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Imara inc. achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Jun 30 2022 period, Imara's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Imara inc. achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
IMRA's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for IMRA's Competitors
Capital Expenditures Growth for Imara's Suppliers
Capital Expenditures Growth for IMRA's Customers

You may also want to know
IMRA's Annual Growth Rates IMRA's Profitability Ratios IMRA's Asset Turnover Ratio IMRA's Dividend Growth
IMRA's Roe IMRA's Valuation Ratios IMRA's Financial Strength Ratios IMRA's Dividend Payout Ratio
IMRA's Roa IMRA's Inventory Turnover Ratio IMRA's Growth Rates IMRA's Dividend Comparisons



Companies with similar Capital Expenditures jump for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jun 30 2022
Novan Inc.-0.21%$ -0.213 millions
Endo International Plc-0.32%$ -0.317 millions
Molecular Templates Inc.-0.59%$ -0.590 millions
Atricure Inc.-0.69%$ -0.688 millions
Seagen Inc.-0.83%$ -0.833 millions
Boston Scientific Corporation-0.94%$ -0.943 millions
Ispecimen inc.-1.10%$ -1.098 millions
Eli Lilly And Company-2.70%$ -2.701 millions
Dynatronics Corporation-2.88%$ -2.878 millions
Amicus Therapeutics inc.-3.01%$ -3.005 millions
Hanger inc.-3.02%$ -3.016 millions
Encompass Health Corporation-3.39%$ -3.390 millions
Surmodics Inc.-4.44%$ -4.440 millions
Davita Inc.-4.80%$ -4.797 millions
Tenaya Therapeutics Inc.-5.07%$ -5.067 millions
Abiomed Inc.-5.40%$ -5.397 millions
Healthcare Services Group Inc.-5.63%$ -5.632 millions
Axon Enterprise inc.-5.85%$ -5.848 millions
Cidara Therapeutics Inc.-5.88%$ -5.882 millions
Viatris Inc.-6.05%$ -6.047 millions
Mimedx Group Inc.-6.17%$ -6.173 millions
Vericel Corporation-6.47%$ -6.468 millions
Rackspace Technology Inc.-6.53%$ -6.529 millions
Caremax Inc.-6.61%$ -6.614 millions
Sight Sciences Inc.-7.32%$ -7.317 millions
Abbott Laboratories-8.23%$ -8.232 millions
National Healthcare Corp-8.45%$ -8.451 millions
1life Healthcare Inc.-8.56%$ -8.561 millions
Urogen Pharma Ltd.-8.70%$ -8.696 millions
F star Therapeutics Inc.-8.95%$ -8.951 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

STMH's Profile

Stock Price

STMH's Financials

Business Description

Fundamentals

Charts & Quotes

STMH's News

Suppliers

STMH's Competitors

Customers & Markets

Economic Indicators

STMH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071